Abbott Laboratories (ABT)
NYSE: ABT · Real-Time Price · USD
127.78
+2.32 (1.85%)
Dec 15, 2025, 10:49 AM EST - Market open

Abbott Laboratories Revenue

Abbott Laboratories had revenue of $11.37B in the quarter ending September 30, 2025, with 6.90% growth. This brings the company's revenue in the last twelve months to $43.84B, up 6.37% year-over-year. In the year 2024, Abbott Laboratories had annual revenue of $41.95B with 4.59% growth.

Revenue (ttm)
$43.84B
Revenue Growth
+6.37%
P/S Ratio
4.98
Revenue / Employee
$384,588
Employees
114,000
Market Cap
222.19B

Revenue Chart

Revenue History

Fiscal Year EndRevenueChangeGrowth
Dec 31, 202441.95B1.84B4.59%
Dec 31, 202340.11B-3.54B-8.12%
Dec 31, 202243.65B578.00M1.34%
Dec 31, 202143.08B8.47B24.47%
Dec 31, 202034.61B2.70B8.48%
Dec 31, 201931.90B1.33B4.34%
Dec 31, 201830.58B3.19B11.64%
Dec 31, 201727.39B6.54B31.35%
Dec 31, 201620.85B448.00M2.20%
Dec 31, 201520.41B158.00M0.78%
Dec 31, 201420.25B590.00M3.00%
Dec 31, 201319.66B607.00M3.19%
Dec 31, 201219.05B-2.36B-11.01%
Dec 31, 201121.41B-13.76B-39.13%
Dec 31, 201035.17B4.40B14.31%
Dec 31, 200930.76B1.24B4.19%
Dec 31, 200829.53B3.61B13.94%
Dec 31, 200725.91B3.44B15.30%
Dec 31, 200622.48B138.51M0.62%
Dec 31, 200522.34B--

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company NameRevenue
UnitedHealth Group435.16B
Johnson & Johnson92.15B
Merck & Co.64.24B
AbbVie59.64B
Eli Lilly and Company59.42B
AstraZeneca58.13B
Novartis AG56.37B
Novo Nordisk49.58B
Revenue Rankings